Government, purchase contract vaccine data received in advance
Preparation for vaccination as soon as the first quantity is received
2nd quarter introduction, except Janssen, should be hit twice… ‘September group immunity’ target is tight
In a press release released on December 31 last year (local time), Moderna said, “To support the Korean government’s goal of supplying the vaccine to the people as quickly as possible, we have signed a contract to supply 40 million doses (for 20 million people) vaccine. We confirm that we have concluded.” He said, “The vaccine supply will start in May.” Modena also explained, “We will cooperate with regulatory authorities to obtain the necessary approvals prior to distribution of the vaccine as it is currently not approved for use in Korea.”
The government is preparing to start vaccination as soon as the first volume of the contracted vaccine is introduced. The Ministry of Food and Drug Safety is currently reviewing data on AstraZeneca and Pfizer Janssen Modena vaccines. In order to vaccinate the vaccine, it must go through approval review (within 40 days) and national shipment approval (within 20 days) from the Ministry of Food and Drug Safety. If the procedure starts after introduction, the inoculation is bound to be delayed.
“The Ministry of Food and Drug Safety is in the process of preparing for approval while reviewing the non-clinical data of the vaccine in advance,” said Jung Eun-kyung, head of the Korea Centers for Disease Control and Prevention. I am managing it.”
View larger-The first vaccination is expected to start with the AstraZeneca vaccine (for 10 million people), which will be introduced in February and March. The UK government approved the emergency use of the AstraZeneca vaccine for the first time in the world on December 30 last year (local time). The Ministry of Food and Drug Safety is also expected to refer to this for review. The second vaccination is likely to be a modder or vaccine coming from May. On December 20 last year (local time), vaccination started locally after approval from the Centers for Disease Control and Prevention (CDC). The Janssen vaccine (for 6 million people) will be introduced in the second quarter of this year (April to June). However, the phase 3 clinical trial of this vaccine has not yet been completed. Further review of safety and efficacy is needed. U.S. health officials said the Janssen vaccine would be approved for emergency use in the next month. In the third quarter (July to September), the introduction of Pfizer vaccines (for 10 million people) will begin. As this product was used first among the corona 19 vaccines, the approval process by the Ministry of Food and Drug Safety is likely to be shortened.
The Agency for Disease Control and Prevention has set a goal to form collective immunity by September this year through vaccination. Except for Janssen, the remaining vaccines should be administered twice every 3 to 4 weeks. However, as supplies are expected to be concentrated in the third quarter, the schedule is tight to complete the two doses by the end of September. In addition, although the outline of the introduction period was revealed, the specific monthly introduction volume is still uncertain. We cannot rule out the possibility that domestic introduction will also be disrupted if the supply of allotment to developed countries that pre-purchased vaccines before us is delayed.
Reporter Jeon Ju-young [email protected]· Kim Ye-yoon
Copyright by dongA.com All rights reserved.
—
–
